CRVS
Corvus Pharmaceuticals Inc.
$7.11
+$0.18(+2.60%)
55
Overall
--
Value
72
Tech
39
Quality
Market Cap
$437.40M
Volume
1.08M
52W Range
$2.54 - $10.00
Target Price
$14.80
Key Metrics Overview
| Market Cap | $437.40M | P/E Ratio | N/A |
| 52W High | $10.00 | 52W Low | $2.54 |
| Div Yield | N/A | Payout Ratio | 0.0% |
| EPS Growth 3Y | N/A | 52W Position | 61.3% |
| Overall Score | 55 | Value Score | -- |
| Quality Score | 39 | Technical Score | 72 |
Growth Analysis
| EPS Current Est | $-0.51 | EPS Next Est | $-0.6 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
No data available
EBITDA (5Y)
No data available
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CRVS | $7.11 | +2.6% | 1.08M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Corvus Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW